SlideShare a Scribd company logo
Cardiovascular Effects Of
Obesity
Dr. Atul Dixit, Mohak Robotics & Bariatrics, Indore.
Obesity: A Global Epidemic!
Dramatic increases in both adults & children
Explosive increase in number of people with Metabolic Syndrome (MetS)
MetS associated with increased risk of both diabetes & cardiovascular disease
(CVD)
41 sites on the genome identified as possible links to development of Obesity in a
favourable environment
A variety of adaptations/alterations in cardiac structure & function occur in the
individual as adipose tissue accumulates in excess amount, even in absence of
co-morbidities
On the whole:
Overweight or Obesity predisposes or is associated with numerous cardiac
complications such as:
Coronary heart disease (CHD)
Heart failure
Sudden death (Sudden Cardiac Arrest or SCA)
Cardiomyopathy of Obesity (Adipositas Cordis)
Initially, the fatty heart is probably not an infiltrative process but most likely a
metaplasic phenomenon.
Cords of cells can gradually accumulate fat between muscle fibers and/or result in
myocyte degeneration resulting in cardiac dysfunction.
Small irregular aggregates and bands of adipose tissue separate myocardial cells,
a potential result of pressure-induced atrophy from the intervening fat.
Through different mechanisms (increased total blood volume, increased cardiac
output, LVH, LVDD, adipositas cordis) obesity may predispose to heart failure.
Assessment of Obese Individuals & Co-morbidities
Physical examination & ECG often underestimate the presence & extent of cardiac
dysfunction in obese patients.
ECG: like physical examination, the ECG is influenced by morphological changes
induced by obesity such as:
displacement of heart & elevated diaphragm, increased cardiac workload with
associated cardiac hypertrophy, increased distance between the heart & the
recording electrodes induced by accumulation of adipose tissue in chest wall,
associated chronic lung disease secondary to sleep apnea/hypoventilation
syndrome.
ECG changes that may occur in obese individuals:
Increased heart rate, PR interval, QRS interval, QTc interval, QT dispersion, late
potentials, left atrial abnormalities.
ST-T abnormalities, ST depression, Left axis deviation, Flattening of the T wave
(infero-lateral leads).
False positive criteria for inferior myocardial infarction.
Multiple ECG criteria for LVH are present more regularly in MO
Echocardiography:
In the past, obesity-induced cardiac abnormalities were found post-mortem.
Differentiation between subepicardial adipose tissue & pericardial effusion is often
difficult and epicardial adipose tissue is known to be e common cause of
false-positive effusion.
Venous Insufficiency, Venous Thrombosis &
Pulmonary Embolus:
Pedal edema is a common finding, partly a consequence of elevated ventricular
filling pressure, despite elevation in cardiac output.
Severe sustained lower extremity venous stasis disease in MO leads to pretibial
ulceration & cellulitis. In absence of right heart failure, surgically-induced weight
loss is effective in correcting venous stasis disease in the majority.
Incidence of VTE increased. Increased risk of PE in women, less clear in men.
Hypertension:
Most patients with high BP are overweight; hypertension is more frequent in obese
subjects.
A 10kg higher body weight is associated with a 3.0 mm Hg higher systolendoic &
2.3 mm Hg higher diastolic BP. Leads to an estimated 12% increased risk for CHD
& 24% increased risk for stroke.
Increase in BP is greatest when obesity is of abdominal distribution.
Factors to be considered in linking obesity to Hypertension include: 1). Direct
effects of obesity on hemodynamics: increased blood volume, stroke volume &
cardiac output. 2). Mechanisms linking obesity & an increase in peripheral
vascular resistance: endothelial dysfunction, insulin resistance, sympathetic
nervous system, substances released from adipocytes & sleep apnea.
Coronary Artery Disease
Examination of arteries post-mortem from individuals 15-34 years revealed that
the extent of fatty streaks & advanced lesions (fibrous plaques & plaques with
calcification or ulceration) in the RCA & in the abdominal aorta were associated
with obesity and with the size of the abdominal panniculus. PDAY study.
Of note, the maximal density of macrophages/mm2 in the lesions was associated
with visceral obesity.
Follow up data over more than two decades suggests obesity is an independent
predictor of clinical CHD. In the TRACE register, the mortality rate was increased
23% compared with patients who were not abdominally obese.
Congestive Heart Failure
Elevated BMI predisposes to congestive heart failure (CHF) by promoting
hypertension, diabetes & CHD.
There is an increase in the risk of CHF of 5% for men & 7% for women for each
increment of 1U of BMI with the existence of a continuous gradient without
evidence of a threshold.
Arrythmias
In the Framingham study, the annual sudden cardiac mortality rate in obese men
& women was estimated to be ~40 times higher than the rate of unexplained
cardiac arrest in a matched non-obese population.Specifically, in severely obese
men, a 6 & 12 fold excess mortality rate was reported in the age group 35 to 44
and 25 to 34 years respectively.
Prolonged QTc interval was observed in ~30% of subjects with impaired glucose
tolerance & there is a positive association between BMI & QTc.
Extremely obese patients often have a dilated cardiomyopathy, fatal arrhythmias
may be the most frequent cause of death.
Arrhythmias contd....
Obesity & cardiac autonomic nervous system are intrinsically related. High
glucose concentrations may promote increased vasomotor tone & ventricular
instability by reducing nitric oxide availability.
A 10% increase in body weight is associated with a decline in parasympathetic
tone accompanied by a rise in mean heart rate, & conversely heart rate declines
during weight reduction.
It was demonstrated that a 10% weight loss in severely obese patients is
associated with significant improvement in autonomic nervous system cardiac
modulation.
Conclusions
A variety of adaptations/alterations in cardiac structure & function occur as
excessive adipose tissue accumulates, even in the absence of systemic
hypertension or underlying organic heart disease.
To meet increased metabolic needs, circulating blood volume, plasma volume &
cardiac output all increase. The increase in blood volume in turn increases venous
return to the right & left ventricles, eventually producing dilatation of these cardiac
cavities, increasing wall tension. This leads to LVH, accompanied by a decrease in
diastolic chamber compliance, eventually resulting in an increase in LV filling
pressure & LV enlargement. As long as LVH adapts to LV chamber enlargement,
systolic function is preserved.
Cardiovascular effects of obesity

More Related Content

What's hot

Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...
Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...
Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...
HM Learnings
 
Metabolic Syndrome - June 2014
Metabolic Syndrome - June 2014Metabolic Syndrome - June 2014
Metabolic Syndrome - June 2014
Geoffrey Douglas
 
Obesity Grand Rounds by Dr. Susan Beland
Obesity Grand Rounds by Dr. Susan BelandObesity Grand Rounds by Dr. Susan Beland
Obesity Grand Rounds by Dr. Susan Beland
Nick Gowen
 
M1607
M1607M1607
M1607
dotugo
 
Metabolic syndrome: an Asian perspective
Metabolic syndrome: an Asian perspectiveMetabolic syndrome: an Asian perspective
Metabolic syndrome: an Asian perspective
My Healthy Waist
 
Metabolic syndrome
Metabolic syndromeMetabolic syndrome
Metabolic syndrome
mohammed abdulbast
 
Cancer 2018
Cancer 2018Cancer 2018
Cancer 2018
EsserHealth
 
Physical Activity in the Management of Abdominal Obesity
Physical Activity in the Management of Abdominal ObesityPhysical Activity in the Management of Abdominal Obesity
Physical Activity in the Management of Abdominal Obesity
My Healthy Waist
 
Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?
My Healthy Waist
 
Tim Byers Presentations International Congress on Obesity
Tim Byers Presentations International Congress on ObesityTim Byers Presentations International Congress on Obesity
Tim Byers Presentations International Congress on Obesity
WCRF International
 
Metabolic Syndrome
 Metabolic Syndrome Metabolic Syndrome
Metabolic Syndrome
doctorshazly
 
Obesity
ObesityObesity
Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...
Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...
Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...
My Healthy Waist
 
Obesity
ObesityObesity
Obesity
naba al wazen
 
Weight loss among metabolically healthy obese men and women: harmful or benef...
Weight loss among metabolically healthy obese men and women: harmful or benef...Weight loss among metabolically healthy obese men and women: harmful or benef...
Weight loss among metabolically healthy obese men and women: harmful or benef...
PeterJaniszewski
 
Metabolic syndrome
Metabolic syndromeMetabolic syndrome
Metabolic syndrome
Ramadhan Ahmed
 
Exercise and health part 2
Exercise and health part 2Exercise and health part 2
Exercise and health part 2
fathi neana
 
Obesity and cancer(final)
Obesity and cancer(final)Obesity and cancer(final)
Obesity and cancer(final)
TomPeter13
 
Obesity
ObesityObesity
Obesity
Tony Abreu
 
Metabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunctionMetabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunction
Tarek Anis
 

What's hot (20)

Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...
Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...
Metabolic Syndrome- Pathophysiology, Treatment I Insulin Resistance Syndrome ...
 
Metabolic Syndrome - June 2014
Metabolic Syndrome - June 2014Metabolic Syndrome - June 2014
Metabolic Syndrome - June 2014
 
Obesity Grand Rounds by Dr. Susan Beland
Obesity Grand Rounds by Dr. Susan BelandObesity Grand Rounds by Dr. Susan Beland
Obesity Grand Rounds by Dr. Susan Beland
 
M1607
M1607M1607
M1607
 
Metabolic syndrome: an Asian perspective
Metabolic syndrome: an Asian perspectiveMetabolic syndrome: an Asian perspective
Metabolic syndrome: an Asian perspective
 
Metabolic syndrome
Metabolic syndromeMetabolic syndrome
Metabolic syndrome
 
Cancer 2018
Cancer 2018Cancer 2018
Cancer 2018
 
Physical Activity in the Management of Abdominal Obesity
Physical Activity in the Management of Abdominal ObesityPhysical Activity in the Management of Abdominal Obesity
Physical Activity in the Management of Abdominal Obesity
 
Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?
 
Tim Byers Presentations International Congress on Obesity
Tim Byers Presentations International Congress on ObesityTim Byers Presentations International Congress on Obesity
Tim Byers Presentations International Congress on Obesity
 
Metabolic Syndrome
 Metabolic Syndrome Metabolic Syndrome
Metabolic Syndrome
 
Obesity
ObesityObesity
Obesity
 
Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...
Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...
Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk...
 
Obesity
ObesityObesity
Obesity
 
Weight loss among metabolically healthy obese men and women: harmful or benef...
Weight loss among metabolically healthy obese men and women: harmful or benef...Weight loss among metabolically healthy obese men and women: harmful or benef...
Weight loss among metabolically healthy obese men and women: harmful or benef...
 
Metabolic syndrome
Metabolic syndromeMetabolic syndrome
Metabolic syndrome
 
Exercise and health part 2
Exercise and health part 2Exercise and health part 2
Exercise and health part 2
 
Obesity and cancer(final)
Obesity and cancer(final)Obesity and cancer(final)
Obesity and cancer(final)
 
Obesity
ObesityObesity
Obesity
 
Metabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunctionMetabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunction
 

Similar to Cardiovascular effects of obesity

Obesity and Risk Factor.ppt
Obesity and Risk Factor.pptObesity and Risk Factor.ppt
Obesity and Risk Factor.ppt
Ro45Fan1
 
Obesity and risk factor
Obesity and risk factorObesity and risk factor
Obesity and risk factor
Leslie Castañeda
 
Acute myocardial-infraction
Acute myocardial-infraction Acute myocardial-infraction
Acute myocardial-infraction
Sudipto Krishna Dutta
 
Systemic disease involving cardiovascular system
Systemic disease involving cardiovascular systemSystemic disease involving cardiovascular system
Systemic disease involving cardiovascular system
Dr. Md. Ahasanul Kabir Shahin
 
3 angina pectoris
3 angina pectoris3 angina pectoris
3 angina pectoris
Chanukya Vanam . Dr
 
SIHD& ACS.pptx
SIHD& ACS.pptxSIHD& ACS.pptx
SIHD& ACS.pptx
AbrhamMulatu
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Mohammed Musa
 
L5 & 6 effects of htn on vessels & heart 20 (2)
L5 & 6 effects of htn on vessels & heart 20 (2)L5 & 6 effects of htn on vessels & heart 20 (2)
L5 & 6 effects of htn on vessels & heart 20 (2)
imrana tanvir
 
4 myocardial infraction
4 myocardial infraction4 myocardial infraction
4 myocardial infraction
Chanukya Vanam . Dr
 
Cad
CadCad
Cardiovascular disorders
Cardiovascular disordersCardiovascular disorders
Cardiovascular disorders
A-aziz Sultan
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
AmareDejene
 
Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease
ANILKUMAR BR
 
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
Shankar Hemam
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
Namrata Chhabra
 
Atherosclerosis
Atherosclerosis Atherosclerosis
Atherosclerosis
Dr Muhammad Mustansar
 
acutemyocardialinfarction-150625210345-lva1-app6891.pdf
acutemyocardialinfarction-150625210345-lva1-app6891.pdfacutemyocardialinfarction-150625210345-lva1-app6891.pdf
acutemyocardialinfarction-150625210345-lva1-app6891.pdf
shsharma94697
 
Acute Myocardial Infarction
Acute Myocardial InfarctionAcute Myocardial Infarction
Acute Myocardial Infarction
Anwar Siddiqui
 
acute MI.pdf
acute MI.pdfacute MI.pdf
acute MI.pdf
SahanaReddy39
 
Heart diseases
Heart diseasesHeart diseases

Similar to Cardiovascular effects of obesity (20)

Obesity and Risk Factor.ppt
Obesity and Risk Factor.pptObesity and Risk Factor.ppt
Obesity and Risk Factor.ppt
 
Obesity and risk factor
Obesity and risk factorObesity and risk factor
Obesity and risk factor
 
Acute myocardial-infraction
Acute myocardial-infraction Acute myocardial-infraction
Acute myocardial-infraction
 
Systemic disease involving cardiovascular system
Systemic disease involving cardiovascular systemSystemic disease involving cardiovascular system
Systemic disease involving cardiovascular system
 
3 angina pectoris
3 angina pectoris3 angina pectoris
3 angina pectoris
 
SIHD& ACS.pptx
SIHD& ACS.pptxSIHD& ACS.pptx
SIHD& ACS.pptx
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
L5 & 6 effects of htn on vessels & heart 20 (2)
L5 & 6 effects of htn on vessels & heart 20 (2)L5 & 6 effects of htn on vessels & heart 20 (2)
L5 & 6 effects of htn on vessels & heart 20 (2)
 
4 myocardial infraction
4 myocardial infraction4 myocardial infraction
4 myocardial infraction
 
Cad
CadCad
Cad
 
Cardiovascular disorders
Cardiovascular disordersCardiovascular disorders
Cardiovascular disorders
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
 
Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease
 
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS-CARDIO-VASCULAR DISEASES ISCHE...
MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS- CARDIO-VASCULAR DISEASES ISCHE...
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
Atherosclerosis Atherosclerosis
Atherosclerosis
 
acutemyocardialinfarction-150625210345-lva1-app6891.pdf
acutemyocardialinfarction-150625210345-lva1-app6891.pdfacutemyocardialinfarction-150625210345-lva1-app6891.pdf
acutemyocardialinfarction-150625210345-lva1-app6891.pdf
 
Acute Myocardial Infarction
Acute Myocardial InfarctionAcute Myocardial Infarction
Acute Myocardial Infarction
 
acute MI.pdf
acute MI.pdfacute MI.pdf
acute MI.pdf
 
Heart diseases
Heart diseasesHeart diseases
Heart diseases
 

Recently uploaded

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 

Recently uploaded (20)

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 

Cardiovascular effects of obesity

  • 1. Cardiovascular Effects Of Obesity Dr. Atul Dixit, Mohak Robotics & Bariatrics, Indore.
  • 2. Obesity: A Global Epidemic! Dramatic increases in both adults & children Explosive increase in number of people with Metabolic Syndrome (MetS) MetS associated with increased risk of both diabetes & cardiovascular disease (CVD) 41 sites on the genome identified as possible links to development of Obesity in a favourable environment A variety of adaptations/alterations in cardiac structure & function occur in the individual as adipose tissue accumulates in excess amount, even in absence of co-morbidities
  • 3. On the whole: Overweight or Obesity predisposes or is associated with numerous cardiac complications such as: Coronary heart disease (CHD) Heart failure Sudden death (Sudden Cardiac Arrest or SCA)
  • 4. Cardiomyopathy of Obesity (Adipositas Cordis) Initially, the fatty heart is probably not an infiltrative process but most likely a metaplasic phenomenon. Cords of cells can gradually accumulate fat between muscle fibers and/or result in myocyte degeneration resulting in cardiac dysfunction. Small irregular aggregates and bands of adipose tissue separate myocardial cells, a potential result of pressure-induced atrophy from the intervening fat. Through different mechanisms (increased total blood volume, increased cardiac output, LVH, LVDD, adipositas cordis) obesity may predispose to heart failure.
  • 5. Assessment of Obese Individuals & Co-morbidities Physical examination & ECG often underestimate the presence & extent of cardiac dysfunction in obese patients. ECG: like physical examination, the ECG is influenced by morphological changes induced by obesity such as: displacement of heart & elevated diaphragm, increased cardiac workload with associated cardiac hypertrophy, increased distance between the heart & the recording electrodes induced by accumulation of adipose tissue in chest wall, associated chronic lung disease secondary to sleep apnea/hypoventilation syndrome.
  • 6. ECG changes that may occur in obese individuals: Increased heart rate, PR interval, QRS interval, QTc interval, QT dispersion, late potentials, left atrial abnormalities. ST-T abnormalities, ST depression, Left axis deviation, Flattening of the T wave (infero-lateral leads). False positive criteria for inferior myocardial infarction. Multiple ECG criteria for LVH are present more regularly in MO
  • 7. Echocardiography: In the past, obesity-induced cardiac abnormalities were found post-mortem. Differentiation between subepicardial adipose tissue & pericardial effusion is often difficult and epicardial adipose tissue is known to be e common cause of false-positive effusion.
  • 8. Venous Insufficiency, Venous Thrombosis & Pulmonary Embolus: Pedal edema is a common finding, partly a consequence of elevated ventricular filling pressure, despite elevation in cardiac output. Severe sustained lower extremity venous stasis disease in MO leads to pretibial ulceration & cellulitis. In absence of right heart failure, surgically-induced weight loss is effective in correcting venous stasis disease in the majority. Incidence of VTE increased. Increased risk of PE in women, less clear in men.
  • 9. Hypertension: Most patients with high BP are overweight; hypertension is more frequent in obese subjects. A 10kg higher body weight is associated with a 3.0 mm Hg higher systolendoic & 2.3 mm Hg higher diastolic BP. Leads to an estimated 12% increased risk for CHD & 24% increased risk for stroke. Increase in BP is greatest when obesity is of abdominal distribution. Factors to be considered in linking obesity to Hypertension include: 1). Direct effects of obesity on hemodynamics: increased blood volume, stroke volume & cardiac output. 2). Mechanisms linking obesity & an increase in peripheral vascular resistance: endothelial dysfunction, insulin resistance, sympathetic nervous system, substances released from adipocytes & sleep apnea.
  • 10. Coronary Artery Disease Examination of arteries post-mortem from individuals 15-34 years revealed that the extent of fatty streaks & advanced lesions (fibrous plaques & plaques with calcification or ulceration) in the RCA & in the abdominal aorta were associated with obesity and with the size of the abdominal panniculus. PDAY study. Of note, the maximal density of macrophages/mm2 in the lesions was associated with visceral obesity. Follow up data over more than two decades suggests obesity is an independent predictor of clinical CHD. In the TRACE register, the mortality rate was increased 23% compared with patients who were not abdominally obese.
  • 11. Congestive Heart Failure Elevated BMI predisposes to congestive heart failure (CHF) by promoting hypertension, diabetes & CHD. There is an increase in the risk of CHF of 5% for men & 7% for women for each increment of 1U of BMI with the existence of a continuous gradient without evidence of a threshold.
  • 12. Arrythmias In the Framingham study, the annual sudden cardiac mortality rate in obese men & women was estimated to be ~40 times higher than the rate of unexplained cardiac arrest in a matched non-obese population.Specifically, in severely obese men, a 6 & 12 fold excess mortality rate was reported in the age group 35 to 44 and 25 to 34 years respectively. Prolonged QTc interval was observed in ~30% of subjects with impaired glucose tolerance & there is a positive association between BMI & QTc. Extremely obese patients often have a dilated cardiomyopathy, fatal arrhythmias may be the most frequent cause of death.
  • 13. Arrhythmias contd.... Obesity & cardiac autonomic nervous system are intrinsically related. High glucose concentrations may promote increased vasomotor tone & ventricular instability by reducing nitric oxide availability. A 10% increase in body weight is associated with a decline in parasympathetic tone accompanied by a rise in mean heart rate, & conversely heart rate declines during weight reduction. It was demonstrated that a 10% weight loss in severely obese patients is associated with significant improvement in autonomic nervous system cardiac modulation.
  • 14. Conclusions A variety of adaptations/alterations in cardiac structure & function occur as excessive adipose tissue accumulates, even in the absence of systemic hypertension or underlying organic heart disease. To meet increased metabolic needs, circulating blood volume, plasma volume & cardiac output all increase. The increase in blood volume in turn increases venous return to the right & left ventricles, eventually producing dilatation of these cardiac cavities, increasing wall tension. This leads to LVH, accompanied by a decrease in diastolic chamber compliance, eventually resulting in an increase in LV filling pressure & LV enlargement. As long as LVH adapts to LV chamber enlargement, systolic function is preserved.